Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Immunocore Holdings Plc ADR (NQ: IMCR ) 31.70 +0.87 (+2.82%) Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Immunocore Holdings Plc ADR < Previous 1 2 3 4 5 6 Next > A Closer Look at 9 Analyst Recommendations For Immunocore Hldgs October 24, 2024 Via Benzinga Analyst Ratings For Immunocore Hldgs October 07, 2024 Via Benzinga GE Vernova To Rally Over 30%? Here Are 10 Top Analyst Forecasts For Tuesday September 17, 2024 Via Benzinga Analyst Expectations For Immunocore Hldgs's Future September 17, 2024 Via Benzinga Immunocore presents Phase 1 data of brenetafusp, an ImmTAC bispecific targeting PRAME, in patients with ovarian cancer September 14, 2024 From Immunocore Holdings plc Via GlobeNewswire The Latest Analyst Ratings For Immunocore Hldgs August 28, 2024 Via Benzinga Deep Dive Into Immunocore Hldgs Stock: Analyst Perspectives (9 Ratings) August 09, 2024 Via Benzinga Peeling Back The Layers: Exploring Immunocore Hldgs Through Analyst Insights July 10, 2024 Via Benzinga Analyst Expectations For Immunocore Hldgs's Future May 24, 2024 Via Benzinga Immunocore to present at the 2024 Cantor Global Healthcare Conference September 12, 2024 From Immunocore Holdings plc Via GlobeNewswire Immunocore announces transition of Chief Financial Officer August 29, 2024 From Immunocore Holdings plc Via GlobeNewswire Immunocore reports second quarter financial results and provides a business update August 08, 2024 From Immunocore Holdings plc Via GlobeNewswire 3 Small-Cap Stocks with Significant Growth Potential August 06, 2024 As sector rotation continues, it could be time for investors to consider these small-cap growth stocks that institutions love. Via InvestorPlace Where Immunocore Hldgs Stands With Analysts April 29, 2024 Via Benzinga Immunocore Hldgs Stock: A Deep Dive Into Analyst Perspectives (8 Ratings) April 11, 2024 Via Benzinga Immunocore to report second quarter 2024 financial results and host call on August 8, 2024 August 01, 2024 From Immunocore Holdings plc Via GlobeNewswire Immunocore announces randomization of first patient in the global, registrational Phase 3 clinical trial testing brenetafusp for the treatment of first-line advanced or metastatic cutaneous melanoma June 18, 2024 From Immunocore Holdings plc Via GlobeNewswire Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial response June 01, 2024 From Immunocore Holdings plc Via GlobeNewswire Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session June 03, 2024 Via Benzinga Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting PRAME, in immune checkpoint pre-treated cutaneous melanoma patients at ASCO 2024 May 31, 2024 From Immunocore Holdings plc Via GlobeNewswire Immunocore to present at the Jefferies Global Healthcare Conference May 30, 2024 From Immunocore Holdings plc Via GlobeNewswire Immunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating KIMMTRAK for previously treated advanced cutaneous melanoma May 29, 2024 From Immunocore Holdings plc Via GlobeNewswire Why NetEase Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session May 24, 2024 Via Benzinga IMCR Stock Earnings: Immunocore Hldgs Misses EPS, Misses Revenue for Q1 2024 May 08, 2024 IMCR stock results show that Immunocore Hldgs missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. Via InvestorPlace Immunocore reports first quarter financial results and provides a business update May 08, 2024 From Immunocore Holdings plc Via GlobeNewswire Immunocore announces upcoming presentation and posters at ASCO 2024 April 24, 2024 From Immunocore Holdings plc Via GlobeNewswire Immunocore to present at upcoming investor conferences April 04, 2024 From Immunocore Holdings Limited Via GlobeNewswire Billionaire’s Biotech Bets: 3 Stocks Dominating Bill Gates’ Portfolio March 13, 2024 One of the primary features of Bill Gates biotech stocks is they are all working towards a cure for HIV and related illnesses. Via InvestorPlace Immunocore presented two posters at CROI 2024 March 05, 2024 From Immunocore Holdings Limited Via GlobeNewswire Immunocore to present at upcoming investor conferences March 01, 2024 From Immunocore Holdings Limited Via GlobeNewswire < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
